In-patient Study in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is a placebo-controlled study in both healthy normal subjects and patients with
Type 2 Diabetes Mellitus to assess the levels of exenatide in the bloodstream when it is
given for 7 days, and to assess the impact this medication has on various substances in the
blood. Assessments include repeat blood sampling and monitoring of any side effects.